Trump Signs Order to Boost US Drug Manufacturing Ahead of Potential Pharma Tariffs
A key focus of the executive order is cutting red tape to shorten the timelines for building new plants. WASHINGTON—President Donald Trump on Monday signed an executive order aimed at boosting domestic production of prescription drugs and reducing America’s dependence on foreign pharmaceutical supply chains. The order directs the Food and Drug Administration (FDA) to